republic-os/legislation/us/states/co/2019a/hb-19-1131.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Prescription Drug Cost Education	Drug manufacturer, representative, agent, or employee - prescription drug marketing - disclosure of drug information required. The act requires a drug manufacturer, or a representative, agent, or employee of the manufacturer, who while employed by or under contract to represent a manufacturer engages in prescription drug marketing, to provide to a prescriber, in writing, the wholesale acquisition cost of a prescription drug when, in the course of conducting business, the manufacturer, representative, agent, or employee provides information concerning the drug to the prescriber.	us/states/co	Colorado General Assembly	2019A	HB 19-1131	Colorado HB 19-1131 (2019A)	bill		enacted	Faith Winter Sonya Jaquez Lewis	10	22	8	2019-01-25T07:00:00+00:00	2019-05-16T06:00:00+00:00	openstates	ocd-bill/43ecf7fc-aa90-41f1-a15f-2ff761f28660	http://leg.colorado.gov/bills/hb19-1131	e3e012e7d26d5d43c94f956a461d0ee7eecd827d6ff5010a8a8004f9ebfedbe8	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-co

Colorado HB 19-1131 (2019A) — Prescription Drug Cost Education

Drug manufacturer, representative, agent, or employee - prescription drug marketing - disclosure of drug information required. The act requires a drug manufacturer, or a representative, agent, or employee of the manufacturer, who while employed by or under contract to represent a manufacturer engages in prescription drug marketing, to provide to a prescriber, in writing, the wholesale acquisition cost of a prescription drug when, in the course of conducting business, the manufacturer, representative, agent, or employee provides information concerning the drug to the prescriber.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. Committee Amendment (committee substitute) — source
2. Engrossed (03/01/2019) (committee substitute) — source
3. Final Act (05/10/2019) (committee substitute) — source
4. Introduced (01/25/2019) (committee substitute) — source
5. PA1 (02/22/2019) (committee substitute) — source
6. PA2 (03/21/2019) (committee substitute) — source
7. Reengrossed (03/04/2019) (committee substitute) — source
8. Rerevised (03/29/2019) (committee substitute) — source
9. Revised (03/28/2019) (committee substitute) — source
10. Signed Act (05/16/2019) (committee substitute) — source

Votes

• ADOPT CCR — 14–18 (fail) · lower
• REPASS — 41–23 (pass) · lower
• NOTCNCR — 43–20 (pass) · lower
• REPASS — 18–14 (pass) · lower
• ADOPT CCR — 18–14 (pass) · lower
• ADOPT — 42–22 (pass) · lower
• BILL — 22–13 (pass) · lower
• BILL — 40–23 (pass) · lower

Sponsors

• Faith Winter — primary (person)
• Sonya Jaquez Lewis — primary (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2019-05-16T06:00:00+00:00 Governor Signed executive-signature
• 2019-05-10T06:00:00+00:00 Signed by the President of the Senate
• 2019-05-10T06:00:00+00:00 Signed by the Speaker of the House
• 2019-05-10T06:00:00+00:00 Sent to the Governor executive-receipt
• 2019-04-16T06:00:00+00:00 House Consideration of First Conference Committee Report result was to Adopt Committee Report - Repass
• 2019-04-12T06:00:00+00:00 Senate Consideration of First Conference Committee Report result was to Adopt Committee Report - Repass
• 2019-04-10T06:00:00+00:00 First Conference Committee Result was to Adopt Reengrossed w/ Amendments
• 2019-04-01T06:00:00+00:00 House Considered Senate Amendments - Result was to Not Concur - Request Conference Committee
• 2019-03-29T06:00:00+00:00 Senate Third Reading Passed - No Amendments passage, reading-3
• 2019-03-28T06:00:00+00:00 Senate Second Reading Passed with Amendments - Committee, Floor reading-2
• 2019-03-27T06:00:00+00:00 Senate Second Reading Laid Over Daily - No Amendments
• 2019-03-26T06:00:00+00:00 Senate Second Reading Laid Over Daily - No Amendments
• 2019-03-25T06:00:00+00:00 Senate Second Reading Laid Over Daily - No Amendments
• 2019-03-20T06:00:00+00:00 Senate Committee on Health & Human Services Refer Amended to Senate Committee of the Whole referral-committee, committee-passage
• 2019-03-07T07:00:00+00:00 Introduced In Senate - Assigned to Health & Human Services introduction
• 2019-03-04T07:00:00+00:00 House Third Reading Passed - No Amendments passage, reading-3
• 2019-03-01T07:00:00+00:00 House Second Reading Passed with Amendments - Committee, Floor reading-2
• 2019-02-28T07:00:00+00:00 House Second Reading Laid Over Daily - No Amendments
• 2019-02-26T07:00:00+00:00 House Second Reading Laid Over to 02/28/2019 - No Amendments
• 2019-02-25T07:00:00+00:00 House Second Reading Laid Over Daily - No Amendments
• 2019-02-20T07:00:00+00:00 House Committee on Health & Insurance Refer Amended to House Committee of the Whole referral-committee, committee-passage
• 2019-01-25T07:00:00+00:00 Introduced In House - Assigned to Health & Insurance introduction

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/43ecf7fc-aa90-41f1-a15f-2ff761f28660. Confidence: reported (aggregated from official Colorado legislature records).